Merck Wins FDA Nod for RSV Antibody, Tees Up Challenge to Sanofi, AstraZeneca

By /

Merck’s Enflonsia will go up against Sanofi and AstraZeneca’s Beyfortus, which the partners plan to ship out early in the third quarter.

Scroll to Top